The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2012 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2012 AAPM Annual Meeting « Back

    289

    Functions of Transcription Factor Sox11 in Axonal Growth, Target Innervations, and Neuropathic Pain

    Lei Lei, PhD, llei@une.edu1, Jennifer T. Malon, MS1, Kyle S. Draleau, BS1, Brady Butler, BS1, Jordan Faloon, Undergraduate Student2, Aubrey White, Undergraduate Student1, Emilea Y. Lee, Undergraduate Student1, Michael C. Anderson, Undergraduate Student1, Ling Cao, MD PhD1, Edward Bilsky, PhD1, (1) University of New England, Biddeford, Maine, (2) ASPET, Biddeford, Maine

    The transcription factor Sox11 is highly expressed in dorsal root ganglia during development. We demonstrated that Sox11 controls the survival and axonal growth of embryonic sensory neurons. In Sox11 null mice, sensory neurons undergo excessive cell death and display significantly reduced cutaneous projections. Sox11 is also one of the few transcription factors whose expression is highly up-regulated after peripheral nerve injury. We hypothesize that the upregulation of Sox11 is an adaptive change on the part of the nervous system to promote homeostasis and reinnervation of distal territories, thus protecting against the development of neuropathic pain. Alternatively, the upregulation of Sox11 may lead to transcriptional changes in nociceptors that contribute to pain hypersensitivity. To test these hypotheses, we generated nociceptor-specific Sox11 conditional knockout (CKO) mice using the Cre-loxP-mediated gene targeting system with the Nav1.8-Cre line that expresses Cre recombinase specifically in nociceptors. These CKO mice are viable and grossly normal. We are currently testing whether the upregulation of Sox11 after nerve injury is anti-nociceptive or pro-nociceptive in two nerve injury models - sciatic nerve crush which allows for nerve regeneration, and L5 spinal nerve transection which does not allow for nerve regeneration. We will determine whether Sox11 is required in nociceptors to promote axonal growth and target reinnervation post-nerve injury. These studies should provide insight into the pathophysiology of neuropathic pain states and suggest novel treatment strategies for prevention or reversal of these states. References: 1)Lin, L., Lee, V., Wang, Y., Lin, J., Sock, E., Wegner, M., and Lei, L. (2011). Sox11 regulates survival and axonal growth of embryonic sensory neurons. Developmental Dynamics 240, 52-64.

    Funding: None

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In